Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 2,364 | 1,029 | 3,826 | 3,565 | 4,263 |
| Gross Profit | 2,364 | 1,029 | 3,826 | 3,565 | 4,263 |
| Operating Expenses | 42,373 | 133,328 | 98,479 | 8,198 | 10,036 |
| Operating Income | -40,009 | -132,299 | -94,653 | -4,633 | -5,773 |
| Other Income | 3,887 | 2,807 | 2,019 | 288 | 216 |
| Pre-tax Income | -36,122 | -129,492 | -92,634 | -4,345 | -5,557 |
| Net Income Continuous | -36,122 | -129,492 | -92,634 | -4,345 | -5,557 |
| Net Income | $-36,122 | $-129,492 | $-92,634 | $-4,345 | $-5,557 |
| EPS Basic Total Ops | -0.60 | -2.51 | -4.21 | -0.36 | -0.46 |
| EPS Basic Continuous Ops | -0.60 | -2.51 | -4.22 | -0.36 | -0.46 |
| EPS Diluted Total Ops | -0.60 | -2.51 | -4.21 | -0.36 | -0.46 |
| EPS Diluted Continuous Ops | -0.60 | -2.51 | -4.22 | -0.36 | -0.46 |
| EPS Diluted Before Non-Recurring Items | -0.49 | -0.34 | -0.54 | N/A | N/A |
| EBITDA(a) | $-39,688 | $-132,574 | $-95,240 | $-4,135 | $-5,616 |